Proteoform’s ProTrap XG is a disposable cartridge that provides fast, reproducible, and robust results. It solves one of the biggest challenges in proteomics research, sample prep throughput. The ProTrap XG helps proteomics researchers gain important workflow efficiencies so that new prevention, diagnosis, and treatment solutions for precision medicine can reach patients faster.
Since the 1950’s, liquid chromatography columns have relied on randomly structured packed-bed or monolith stationary phases. After decades of incremental improvement, this technology is reaching its limits. The inherent unordered nature leads to peak dispersion, limited separation efficiency and poor reproducibility.
Pharmafluidics µPACᵀᴹ pillar array chromatography introduces a paradigm shift by fundamentally rethinking the type of stationary phase used to achieve separation and introducing perfect order.
New Objective, Inc. is a privately owned and operated company, co-founded by Gary Valaskovic, Research Fellow and Emily Ehrenfeld, CEO, in January, 1997 in Cambridge, MA. The company holds a sales office located in Shanghai, China, research headquarters in Woburn, MA and corporate headquarters in Littleton, MA with global sales and distribution in North America, Europe, China, South America and Australia. New Objective is developing revolutionary analytical solutions for nanoflow and microflow LC-MS platforms and applications used for disease prediction, diagnosis and treatment, built on the innovative high-performance technology of SilicaTip, PicoFrit and TaperTip.
Evosep aims to improve quality of life and patient care by radically innovating how protein based clinical diagnostics are performed, initially through collaborations with world-leading scientists about developing new technologies and solutions to make sample separation 10 times faster and 100 times more robust than today’s alternatives.